Landos Biopharma, Inc. 3 SEC Filings

Filed On	Filing
01 Jun 2023	Form 3: Batycky Alka, Director No securities owned
07 Sep 2022	Form 3: Cataldi Fabio, Chief Medical Officer No securities owned
22 Jun 2022	Form 3: Oakes Gregory, Director No securities owned
26 May 2022	Form 3: Truesdell Patrick, Vice President and Controller
10 Mar 2022	Form 3: Adsett Roger, Director Holds 0 shares of No securities beneficially owned
16 Nov 2021	Form 3: Bitar Patricia L, Interim CFO Holds 0 shares of No securities beneficially owned
31 Aug 2021	Form 3: Callori Fred, Director Holds 0 shares of No securities beneficially owned
17 May 2021	Form 3: Mayleben Timothy M, Director No securities owned
12 Apr 2021	Form 3: Girao Tiago, Director No securities owned
04 Feb 2021	Form 3: Rtw INVESTMENTS, Lp, 10% owner
03 Feb 2021	Form 3: Perceptive Advisors Llc, Director and 4 others Holds 3,090,924 shares of Common Stock
03 Feb 2021	Form 3: Wong Roderick, Director
03 Feb 2021	Form 3: Poukalov Konstantin, Director
03 Feb 2021	Form 3: Hontecillas Raquel, Chief Scientific Officer Holds 182,490 shares of Common Stock
03 Feb 2021	Form 3: Garabedian Christopher Nishan, Director Holds 3,090,924 shares of Common Stock
03 Feb 2021	Form 3: Colombel Jean-Frederic, Director No securities owned
03 Feb 2021	Form 3: Chauhan Jyoti, ED, Global Clinical Operations Holds 91,245 shares of Common Stock
03 Feb 2021	Form 3: Bassaganya-Riera Josep, Director Holds 8,229,881 shares of Common Stock

Comments